{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:43Z","timestamp":1791352003375,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7557","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nature14510","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T05:39:46Z","timestamp":1434001186000},"page":"478-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["A naturally occurring variant of the human prion protein completely prevents prion disease"],"prefix":"10.1038","volume":"522","author":[{"given":"Emmanuel A.","family":"Asante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Smidak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Jeelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Jakubcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyma","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Richard-Londt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D. F.","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"BFnature14510_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519\u2013550 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnature14510_CR2","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1056\/NEJMoa0809716","volume":"361","author":"S Mead","year":"2009","unstructured":"Mead, S. et al. A novel protective prion protein variant that colocalizes with kuru exposure. N. Engl. J. Med. 361, 2056\u20132065 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnature14510_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351 (2013).","journal-title":"Nature"},{"key":"BFnature14510_CR4","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-V","volume":"337","author":"J Collinge","year":"1991","unstructured":"Collinge, J., Palmer, M. S. & Dryden, A. J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337, 1441\u20131442 (1991).","journal-title":"Lancet"},{"key":"BFnature14510_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340\u2013342 (1991).","journal-title":"Nature"},{"key":"BFnature14510_CR6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jnnp.2004.048660","volume":"76","author":"J Collinge","year":"2005","unstructured":"Collinge, J. Molecular neurology of prion disease. J. Neurol. Neurosurg. Psychiatry 76, 906\u2013919 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnature14510_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1083320","volume":"300","author":"S Mead","year":"2003","unstructured":"Mead, S. et al. Balancing selection at the prion protein gene consistent with prehistoric kuru-like epidemics. Science 300, 640\u2013643 (2003).","journal-title":"Science"},{"key":"BFnature14510_CR8","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1073\/pnas.0809170106","volume":"106","author":"SV Antonyuk","year":"2009","unstructured":"Antonyuk, S. V. et al. Crystal structure of human prion protein bound to a therapeutic antibody. Proc. Natl Acad. Sci. USA 106, 2554\u20132558 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14510_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0140-6736(99)05128-4","volume":"354","author":"J Collinge","year":"1999","unstructured":"Collinge, J. Variant Creutzfeldt-Jakob disease. Lancet 354, 317\u2013323 (1999).","journal-title":"Lancet"},{"key":"BFnature14510_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge, J. & Clarke, A. A general model of prion strains and their pathogenicity. Science 318, 930\u2013936 (2007).","journal-title":"Science"},{"key":"BFnature14510_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(05)78358-6","volume":"351","author":"S Shibuya","year":"1998","unstructured":"Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J. & Kitamoto, T. Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet 351, 419 (1998).","journal-title":"Lancet"},{"key":"BFnature14510_CR12","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1093\/emboj\/cdf653","volume":"21","author":"EA Asante","year":"2002","unstructured":"Asante, E. A. et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358\u20136366 (2002).","journal-title":"EMBO J."},{"key":"BFnature14510_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2004.01.049","volume":"360","author":"EA Asante","year":"2004","unstructured":"Asante, E. A., Li, Y. G., Gowland, I., Jefferys, J. G. & Collinge, J. Pathogenic human prion protein rescues PrP null phenotype in transgenic mice. Neurosci. Lett. 360, 33\u201336 (2004).","journal-title":"Neurosci. Lett."},{"key":"BFnature14510_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1126\/science.1103932","volume":"306","author":"JD Wadsworth","year":"2004","unstructured":"Wadsworth, J. D. et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793\u20131796 (2004).","journal-title":"Science"},{"key":"BFnature14510_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2990.2010.01129.x","volume":"36","author":"JD Wadsworth","year":"2010","unstructured":"Wadsworth, J. D., Asante, E. A. & Collinge, J. Contribution of transgenic models to understanding human prion disease. Neuropathol. Appl. Neurobiol. 36, 576\u2013597 (2010).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnature14510_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/378779a0","volume":"378","author":"J Collinge","year":"1995","unstructured":"Collinge, J. et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779\u2013783 (1995).","journal-title":"Nature"},{"key":"BFnature14510_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill, A. F. et al. The same prion strain causes vCJD and BSE. Nature 389, 448\u2013450 (1997).","journal-title":"Nature"},{"key":"BFnature14510_CR18","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1073\/pnas.0604292103","volume":"103","author":"EA Asante","year":"2006","unstructured":"Asante, E. A. et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc. Natl Acad. Sci. USA 103, 10759\u201310764 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14510_CR19","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1073\/pnas.0800190105","volume":"105","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth, J. D. et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc. Natl Acad. Sci. USA 105, 3885\u20133890 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14510_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685\u2013690 (1996).","journal-title":"Nature"},{"key":"BFnature14510_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce, M. E. et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498\u2013501 (1997).","journal-title":"Nature"},{"key":"BFnature14510_CR22","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.1073\/pnas.182425299","volume":"99","author":"V Perrier","year":"2002","unstructured":"Perrier, V. et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl Acad. Sci. USA 99, 13079\u201313084 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14510_CR23","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1074\/jbc.M809254200","volume":"284","author":"M Hizume","year":"2009","unstructured":"Hizume, M. et al. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J. Biol. Chem. 284, 3603\u20133609 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnature14510_CR24","doi-asserted-by":"publisher","first-page":"e1002275","DOI":"10.1371\/journal.ppat.1002275","volume":"7","author":"JF Striebel","year":"2011","unstructured":"Striebel, J. F., Race, B., Meade-White, K. D., LaCasse, R. & Chesebro, B. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog. 7, e1002275 (2011).","journal-title":"PLoS Pathog."},{"key":"BFnature14510_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nsmb.2031","volume":"18","author":"S DiSalvo","year":"2011","unstructured":"DiSalvo, S., Derdowski, A., Pezza, J. A. & Serio, T. R. Dominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation. Nature Struct. Mol. Biol. 18, 486\u2013492 (2011).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnature14510_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H B\u00fceler","year":"1993","unstructured":"B\u00fceler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339\u20131347 (1993).","journal-title":"Cell"},{"key":"BFnature14510_CR27","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1098\/rstb.2008.0071","volume":"363","author":"MP Alpers","year":"2008","unstructured":"Alpers, M. P. The epidemiology of kuru: monitoring the epidemic from its peak to its end. Phil. Trans. R. Soc. Lond. B 363, 3707\u20133713 (2008).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BFnature14510_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill, A. F. et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126, 1333\u20131346 (2003).","journal-title":"Brain"},{"key":"BFnature14510_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1099\/vir.0.007930-0","volume":"90","author":"EA Asante","year":"2009","unstructured":"Asante, E. A. et al. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J. Gen. Virol. 90, 546\u2013558 (2009).","journal-title":"J. Gen. Virol."},{"key":"BFnature14510_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-59745-234-2_14","volume":"459","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth, J. D. et al. Molecular diagnosis of human prion disease. Methods Mol. Biol. 459, 197\u2013227 (2008).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature14510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14510","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:32:09Z","timestamp":1684420329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature14510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"7557","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnature14510"],"URL":"https:\/\/doi.org\/10.1038\/nature14510","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725547364.793507989","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"28 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company in the field of prion diagnosis, decontamination and therapy. D-Gen supplied the ICSM 35 antibody used in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}